Click to Share
 

Paclitaxel Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Lipomedics Inc
Lipomedics Inc. will present the poster entitled "Injectable Phospholipid-Coated Nanoparticles Loaded with Paclitaxel: Influence of Lipid Composition, Methods of Preparation, Drug Concentration and Storage Temperatures".
By IGDRASOL
IGDRASOL will present updates on Cynviloq™, its late clinical stage paclitaxel nanoparticle formulation.
12094030
By IGDRASOL
Sorrento Therapeutics, Inc. ("STI"; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company focused on the development of oncologic agents for the treatment of cancers.
12078760
By IGDRASOL
IGDRASOL today announced that the Company’s Chief Scientific Officer, Kouros Motamed, Ph.D., will present at the Breakthroughs in Basic & Translational Cancer Research Conference, February 25th, 2013, Maui, HI.
12062970
By IGDRASOL
IGDRASOL today announced that the Company’s Chief Operating Officer, Larn Hwang, Ph.D., will present at the Tumor Invasion and Metastasis conference, January 21st , 2013, San Diego, CA.
12049153
By IGDRASOL
IGDRASOL today announced that Dr. Vuong Trieu, CEO of IGDRASOL, will discuss an overview of the company and the clinical development program for IG-001: a chemical polymer-bound nanoparticle paclitaxel entering phase III clinical testing.

All Press Releases

By Lipomedics Inc
Lipomedics Inc. will present the poster entitled "Injectable Phospholipid-Coated Nanoparticles Loaded with Paclitaxel: Influence of Lipid Composition, Methods of Preparation, Drug Concentration and Storage Temperatures".
By IGDRASOL
IGDRASOL will present updates on Cynviloq™, its late clinical stage paclitaxel nanoparticle formulation.
12094030
By IGDRASOL
Sorrento Therapeutics, Inc. ("STI"; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company focused on the development of oncologic agents for the treatment of cancers.
12078760
By IGDRASOL
IGDRASOL today announced that the Company’s Chief Scientific Officer, Kouros Motamed, Ph.D., will present at the Breakthroughs in Basic & Translational Cancer Research Conference, February 25th, 2013, Maui, HI.
12062970
By IGDRASOL
IGDRASOL today announced that the Company’s Chief Operating Officer, Larn Hwang, Ph.D., will present at the Tumor Invasion and Metastasis conference, January 21st , 2013, San Diego, CA.
12049153
By IGDRASOL
IGDRASOL today announced that Dr. Vuong Trieu, CEO of IGDRASOL, will discuss an overview of the company and the clinical development program for IG-001: a chemical polymer-bound nanoparticle paclitaxel entering phase III clinical testing.
12044119
By IGDRASOL
Personalization of paclitaxel therapy by combination of next generation nanoparticle paclitaxel and point-of-care therapeutic drug monitoring and biomarker testing.
By Soumyajit
Ajikumar Parayil , an Indian scientist from the Massachusetts Institute of Technology (MIT), has helped Coax E. Coli Bacteria to produce Taxadiene which is a precursor compound for Paclitaxel
By Sahajanand Medical Technologies Pvt. Ltd.
Sahajanand Medical Technologies received positive results of nine month PAINT trials for Drug eluting stents, Infinnium and Supralimus. The results unveiled during plenary session of EuroPCR 2008-Barcelona.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share